Joon Hyun
Director, Korea Investment Partners US Inc.
Sam Broder, MD
Former Director of the National Cancer Institute (NCI)
Samuel Broder is the former head of the National Cancer Institute (NCI), the largest and most important Agency for cancer research in the world. President Ronald Reagan appointed Dr. Broder to serve as Director of the NCI in 1989, and he held the position for six years. While at the NCI, he also oversaw the … Read more
Daniel L. Flynn, PhD
BOD Chair, Former Founder, CSO, Deciphera Pharmaceuticals
Daniel L. Flynn PhD is recently retired from Deciphera Pharmaceuticals, Inc., a company he founded in 2003. While at Deciphera during 2003-2023, he held positions of Chief Executive Officer and more recently Executive Vice President and Chief Scientific Officer. He has 40 years of experience within the pharma and biotechnology industry. His research interests are focused … Read more
Casey Cunningham, MD
Chief Scientific Officer, Santé Ventures
Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures. Dr. Cunningham received his fellowship training in oncology and hematology at the Harvard Medical School, where he subsequently served on the faculty for a number of years. In 1999, he became the Associate Director of the Mary Crowley Cancer Research Institute in Dallas, Tx. … Read more
Greg Hamilton
President, Brightstar; CIO, Americo
Laurent Humeau, PHD
Chief Scientific Officer, Inovio Pharmaceuticals
Laurent Humeau is Chief Scientific Officer at Inovio. He works to ensure continuous and strategic growth of INOVIO’s pipeline by introducing a constant flow of innovative concepts and cycling them from early-stage discovery and development through clinical application and patient monitoring. He provides technical and strategic leadership across multiple teams that are essential to upstream … Read more
Jose Ochoa
Partner, Flerie Invest
José Ochoa is a Venture Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 25 companies in the US, UK, Sweden and Israel. With over 25 years of experience in the life sciences sector, José has successfully executed a variety of transactions, including mergers, acquisitions, joint ventures, and … Read more
Dennis Walsh
CFO, Americo
Niranjan Y. Sardesai, PhD
Founder, President & CEO
Dr. Sardesai founded Geneos and has led the growth of Geneos into a Phase2b clinical stage company. He is an experienced biopharma leader, driving the company’s strategic vision and partnering & financing activities. He led the development of the company’s GT-EPIC(TM) platform and is an inventor on a number of foundational patents in the field … Read more
Niranjan Y. Sardesai, PhD
Founder, President & CEO
Dr. Sardesai founded Geneos and has led the growth of Geneos into a Phase2b clinical stage company. He is an experienced biopharma leader, driving the company’s strategic vision and partnering & financing activities. He led the development of the company’s GT-EPIC(TM) platform and is an inventor on a number of foundational patents in the field … Read more